openPR Logo
Press release

Peraso (NASDAQ: PRSO) Gains Momentum as a Leader in Emerging mmWave Technology, Stock Rises 17.32%

06-13-2024 11:36 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: ABNewswire

Peraso (NASDAQ: PRSO) Gains Momentum as a Leader in Emerging

Peraso (NASDAQ: PRSO) has established itself as a prominent figure in the rapidly expanding mmWave technology market, gaining notable recognition in this sector. On Wednesday, June 12, 2024, the stock experienced a surge of 17.32%, closing at $1.49 with a trading volume of 246,526 shares. Furthermore, Ladenburg Thalmann, a distinguished Wall Street firm since 1876, initiated coverage of Peraso on the same day.

Image: https://www.abnewswire.com/uploads/6eee816fe47a2541176b838e7b661093.jpg

According to research by Grandview Research in January 2024, the global mmWave market reached $3.75 billion in 2023. The study indicates that the application of mmWave technology in consumer-related sectors could drive a new market, creating a potential paradigm shift and leading to a compound annual growth rate (CAGR) of around 40% until 2030.

The mmWave technology market is projected to exceed $55 billion by the end of the decade, fueled by the growing use of bandwidth-intensive applications and the demand for high-speed IoT solutions. Established in 2009, Peraso has been dedicated to mmWave solutions, emerging as the leading player in mmWave device production and pioneering high-volume mmWave production test methodologies.

Furthermore, Peraso's industry profile continues to rise, the company will participate in the 16th Annual CEO Investor Summit 2024. The event will take place at the St. Regis Hotel in San Francisco, California, on July 10. Peraso's CEO, Ron Glibbery, and CFO, Jim Sullivan, will attend the summit.

Several major public companies in the millimeter wave (mmWave) technology sector include: AT&T Inc. (NYSE: T), Nokia Corporation (NYSE: NOK), Ericsson (NASDAQ: ERIC), Qualcomm Incorporated (NASDAQ: QCOM), among others.

Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content."TSR" is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. "TSR" authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. "TSR" has not been compensated to produce content related to "Any Companies" appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.

Media Contact
Company Name: The Street Reports
Contact Person: Editor
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=peraso-nasdaq-prso-gains-momentum-as-a-leader-in-emerging-mmwave-technology-stock-rises-1732]
Country: United States
Website: http://www.thestreetreports.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Peraso (NASDAQ: PRSO) Gains Momentum as a Leader in Emerging mmWave Technology, Stock Rises 17.32% here

News-ID: 3538517 • Views:

More Releases from ABNewswire

Digital Printing Service Support in Nazareth, PA Expanded by Sign Textile to Cover Allentown, Philadelphia, Trenton, and Princeton Areas
Digital Printing Service Support in Nazareth, PA Expanded by Sign Textile to Cov …
Sign Textile, a full-service digital printing company based in Nazareth, PA, has expanded its production and fulfillment support to businesses across Allentown, Philadelphia, Trenton, and Princeton. The company now offers direct access to custom outdoor signs, banner printing, vehicle wrap services, large format printing, and custom textile products across the broader Pennsylvania and New Jersey region. Orders are available online at signtextile.com. Digital Printing Service in Nazareth, PA Digital printing service [https://www.google.com/maps/place/Sign+Textile/@40.7385309,-75.3075722,794m/data=!3m2!1e3!4b1!4m6!3m5!1s0x89c4698e5e06db87:0xec2c645ea7b860f8!8m2!3d40.7385309!4d-75.3075722!16s%2Fg%2F11zk5427c5?hl=en-GB&entry=ttu&g_ep=EgoyMDI2MDIyMy4wIKXMDSoASAFQAw%3D%3D#:~:text=digital%20printing%20service]
CoreAge Rx Raises the Bar on Medication Delivery With Free 2-Day Shipping, Temperature-Controlled Packaging, and a Fully Doorstep-to-Patient Experience
CoreAge Rx Raises the Bar on Medication Delivery With Free 2-Day Shipping, Tempe …
As GLP-1 demand continues to grow across the United States, CoreAge Rx delivers compounded Semaglutide and Tirzepatide directly to patients' doors with speed, discretion, and pharmaceutical-grade handling at no extra cost. Image: https://www.abnewswire.com/upload/2026/02/97f63fd2a72edd923f925e1750cfbd14.jpg CoreAge Rx, a LegitScript-certified telehealth weight management provider based in Wichita Falls, Texas, has built a medication delivery model that independent reviewers and patients consistently describe as one of the strongest in the GLP-1 telehealth space. Free 2-day shipping
CoreAge Rx Builds Its GLP-1 Program Around Patient Support That Goes Beyond the Prescription
CoreAge Rx Builds Its GLP-1 Program Around Patient Support That Goes Beyond the …
With 24/7 access, rapid response times, dedicated care coordinators, and physician continuity throughout treatment, CoreAge Rx has set a new standard for what patient support looks like in telehealth weight management. Image: https://www.abnewswire.com/upload/2026/02/79b953c7d7b86bdc830623292680666e.jpg CoreAge Rx, a LegitScript-certified telehealth weight management provider based in Wichita Falls, Texas, has built a patient support model that independent reviewers consistently identify as one of the most comprehensive in the GLP-1 telehealth space. From 24/7 access across
Healthy for Wellness Has Given an In-Depth Analysis of Why CoreAge Rx Is Better Than Its Competitors
Healthy for Wellness Has Given an In-Depth Analysis of Why CoreAge Rx Is Better …
Image: https://www.abnewswire.com/upload/2026/02/850d8bbc779e7d12fe40cc6941e07be3.jpg Healthy for Wellness has published an in-depth analysis [https://healthyforwellness.com/healthy-for-wellness-has-given-an-in-depth-analysis-of-why-coreage-rx-is-better-than-its-competitors/]examining why CoreAge Rx stands out within the growing GLP-1 prescription weight management space. The review evaluates the company's physician-supervised structure, telehealth-based accessibility, compounded GLP-1 medication program, and patient-centered model in comparison to other providers operating in the same category. CoreAge Rx [https://www.coreagerx.com/] operates as a prescription-based telehealth program that provides compounded GLP-1 medications for eligible adults seeking medically supervised weight management

All 5 Releases


More Releases for Peraso

Undervalued Tech: Peraso Inc's (NASDAQ: PRSO) True Value Signals Upside - More S …
Mobix Labs recently made the kind of mistake that reveals more about the bidder than the target. Their unsolicited acquisition [https://www.stocktitan.net/news/PRSO/peraso-confirms-receipt-of-unsolicited-non-binding-acquisition-pevb9rjomb71.html] offer for Peraso represents classic bottom-feeding behavior. A 20% premium that exploits market pressure rather than recognizing strategic value. This follows their established pattern of lowball offers to multiple companies. Mobix declined to sign standard confidentiality agreements, indicating they never intended serious due diligence. The timing reveals everything. PerasoInc's (NASDAQ:
Peraso Inc. (NASDAQ: PRSO) Signals Turnaround - Reports Financials August 11, 20 …
Peraso Inc. (NASDAQ: PRSO) a fundamental growth story-driven by military contracts, commercial wins, and sector diversification-is even more compelling. Over the past year, Peraso has strategically expanded its footprint, building a foundation for long-term growth powered by its proprietary 60GHz mmWave technology. Defense Sector: Stealthy Solutions for Modern Battlefields Peraso Inc.'s (NASDAQ: PRSO) entry into the defense sector marks a key inflection point, with its Perspectus module-featuring stealth, low-jamming, narrow-beamforming, and week-long
Peraso (NASDAQ: PRSO) Volume Surges on Takeover News - More Stocks Inside
Mobix Labs, Inc. (NASDAQ: MOBX) has launched an unsolicited, non-binding proposal to acquire Peraso Inc. (NASDAQ: PRSO) in a stock-for-stock deal offering Peraso shareholders a 20% premium over the company's 30-day average share price. The proposed merger would create a stronger player in the high-growth mmWave, defense, and 5G semiconductor sectors-combining Mobix's $10.7M revenue base and ~450% YoY growth with Peraso's accelerating mmWave performance. The combined company is expected to generate
Peraso Inc.'s (NASDAQ: PRSO) Beamforming Technology Gains Military Traction - Se …
Peraso Inc.'s (NASDAQ: PRSO) advanced beamforming technology has proven to be a game-changer in military and dense urban deployments, where secure, reliable, and high-performance communication is critical. Beamforming's ability to direct signals with precision and bend them around obstacles not only maximizes efficiency but also makes transmissions exceptionally difficult to detect or intercept. These stealth capabilities, combined with Peraso's proprietary innovations, have enabled its solutions to excel in active war
Peraso Inc.'s (NASDAQ: PRSO) PERSPECTUS Modules Outperform in 60Ghz FWA Market
Introduction As high-speed internet access spreads around the world, the unlicensed 60GHz (57-71 Ghz) millimeter-wave (mmWave) spectrum offers immense potential for low-cost, low-capex, easily-deployed high-speed wireless communication, especially areas currently underserved by traditional broadband distribution-fiberoptic. Further, However, until recently, purchasing devices to adequately provide mmWave communications for 60Ghz/mmWave broadband deployments has been difficult. Peraso and several other companies have developed and ramped up mass manufacturing of viable 60Ghz solutions for this
Peraso Inc. (NASDAQ: PRSO) Director Invests $127K, Ladenburg Thalmann Coverage, …
On Tuesday, June 11th, Peraso Inc. (NASDAQ: PRSO) Director Ian McWalter acquired 100,000 shares of the company's stock at an average price of $1.27 per share, totalling $127,000. This strategic investment increases McWalter's holdings to 101,246 shares. Image: https://www.abnewswire.com/uploads/9a500d398df4ec1d757968c73f802240.jpg On June 12, 2024, Ladenburg Thalmann, a renowned Wall Street firm since 1876, initiated coverage [https://thestreetreports.com/wp-content/uploads/2024/06/PRSO-Updated-research.pdf] of Peraso Inc. (NASDAQ: PRSO). Research by Grandview Research in January 2024 highlighted the global mmWave market's